Tricuspid Valve Fungal Endocarditis in a Patient with Breast Cancer and an Implantable Chemotherapy Venous Access Port
Author(s) -
Petros Fountoulakis,
A Siama,
A Kalogeris,
Marianthi Iliopoulou,
Athanasios Tsoukas,
Athanasios Manolis
Publication year - 2019
Publication title -
international cardiovascular forum journal
Language(s) - English
Resource type - Journals
eISSN - 2410-2636
pISSN - 2409-3424
DOI - 10.17987/icfj.v16i0.581
Subject(s) - medicine , endocarditis , chemotherapy , breast cancer , venous access , cancer , surgery , catheter
Fungal endocarditis, a rare and lethal infection, is aetiologically connected with Candida and Aspergillus species. Among these two agents, Candida is a common nosocomial infection with increasing rates over the last years and mortality up to 40% in cases of systemic candidiasis. In the present paper, we describe the case of a 58 year old woman with metastatic breast cancer under palliative chemotherapy who was hospitalized for recurrent episodes of fever due to fungal endocarditis of the implantable venous access port. Such cases may elude the attention of the physician and need to be taken into account especially in oncologic patients with implantable devices under chemotherapy regimens. The treatment of Candida endocarditis can be difficult because of the formation of biofilms on prosthetic devices. The prognosis of these patients may be ameliorated with the combination of fungal and invasive treatment.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom